Literature DB >> 20223200

Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo.

Thomas S Hnasko1, Nao Chuhma, Hui Zhang, Germaine Y Goh, David Sulzer, Richard D Palmiter, Stephen Rayport, Robert H Edwards.   

Abstract

Dopamine neurons in the ventral tegmental area (VTA) play an important role in the motivational systems underlying drug addiction, and recent work has suggested that they also release the excitatory neurotransmitter glutamate. To assess a physiological role for glutamate corelease, we disrupted the expression of vesicular glutamate transporter 2 selectively in dopamine neurons. The conditional knockout abolishes glutamate release from midbrain dopamine neurons in culture and severely reduces their excitatory synaptic output in mesoaccumbens slices. Baseline motor behavior is not affected, but stimulation of locomotor activity by cocaine is impaired, apparently through a selective reduction of dopamine stores in the projection of VTA neurons to ventral striatum. Glutamate co-entry promotes monoamine storage by increasing the pH gradient that drives vesicular monoamine transport. Remarkably, low concentrations of glutamate acidify synaptic vesicles more slowly but to a greater extent than equimolar Cl(-), indicating a distinct, presynaptic mechanism to regulate quantal size. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223200      PMCID: PMC2846457          DOI: 10.1016/j.neuron.2010.02.012

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  76 in total

1.  Epiblast-restricted Cre expression in MORE mice: a tool to distinguish embryonic vs. extra-embryonic gene function.

Authors:  M D Tallquist; P Soriano
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

2.  The use of pHluorins for optical measurements of presynaptic activity.

Authors:  S Sankaranarayanan; D De Angelis; J E Rothman; T A Ryan
Journal:  Biophys J       Date:  2000-10       Impact factor: 4.033

3.  Mesoaccumbens dopamine neuron synapses reconstructed in vitro are glutamatergic.

Authors:  M P Joyce; S Rayport
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

4.  Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter.

Authors:  E E Bellocchio; R J Reimer; R T Fremeau; R H Edwards
Journal:  Science       Date:  2000-08-11       Impact factor: 47.728

5.  Estimate of the chloride concentration in a central glutamatergic terminal: a gramicidin perforated-patch study on the calyx of Held.

Authors:  Gareth D Price; Laurence O Trussell
Journal:  J Neurosci       Date:  2006-11-01       Impact factor: 6.167

6.  Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain.

Authors:  Diederik Moechars; Matthew C Weston; Sandra Leo; Zsuzsanna Callaerts-Vegh; Ilse Goris; Guy Daneels; A Buist; M Cik; P van der Spek; Stefan Kass; Theo Meert; Rudi D'Hooge; Christian Rosenmund; R Mark Hampson
Journal:  J Neurosci       Date:  2006-11-15       Impact factor: 6.167

Review 7.  Cocaine, reward, movement and monoamine transporters.

Authors:  G R Uhl; F S Hall; I Sora
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

8.  Widespread recombinase expression using FLPeR (flipper) mice.

Authors:  F W Farley; P Soriano; L S Steffen; S M Dymecki
Journal:  Genesis       Date:  2000 Nov-Dec       Impact factor: 2.487

9.  Seizures induce simultaneous GABAergic and glutamatergic transmission in the dentate gyrus-CA3 system.

Authors:  R Gutiérrez
Journal:  J Neurophysiol       Date:  2000-12       Impact factor: 2.714

10.  Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons.

Authors:  S Takamori; J S Rhee; C Rosenmund; R Jahn
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

View more
  207 in total

1.  Vesicular monoamine and glutamate transporters select distinct synaptic vesicle recycling pathways.

Authors:  Bibiana Onoa; Haiyan Li; Johann A Gagnon-Bartsch; Laura A B Elias; Robert H Edwards
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 2.  Glutamatergic signaling by midbrain dopaminergic neurons: recent insights from optogenetic, molecular and behavioral studies.

Authors:  Tibor Koos; Fatuel Tecuapetla; James M Tepper
Journal:  Curr Opin Neurobiol       Date:  2011-05-31       Impact factor: 6.627

Review 3.  Vesicular and plasma membrane transporters for neurotransmitters.

Authors:  Randy D Blakely; Robert H Edwards
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

4.  Formation of dopamine quinone-DNA adducts and their potential role in the etiology of Parkinson's disease.

Authors:  Muhammad Zahid; Muhammad Saeed; Li Yang; Cheryl Beseler; Eleanor Rogan; Ercole L Cavalieri
Journal:  IUBMB Life       Date:  2011-11-02       Impact factor: 3.885

Review 5.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

Review 6.  Dopamine in motivational control: rewarding, aversive, and alerting.

Authors:  Ethan S Bromberg-Martin; Masayuki Matsumoto; Okihide Hikosaka
Journal:  Neuron       Date:  2010-12-09       Impact factor: 17.173

Review 7.  Dual-transmitter neurons: functional implications of co-release and co-transmission.

Authors:  Christopher E Vaaga; Maria Borisovska; Gary L Westbrook
Journal:  Curr Opin Neurobiol       Date:  2014-05-13       Impact factor: 6.627

8.  Long-term oral kinetin does not protect against α-synuclein-induced neurodegeneration in rodent models of Parkinson's disease.

Authors:  Adam L Orr; Florentine U Rutaganira; Daniel de Roulet; Eric J Huang; Nicholas T Hertz; Kevan M Shokat; Ken Nakamura
Journal:  Neurochem Int       Date:  2017-04-20       Impact factor: 3.921

Review 9.  Heterogeneity in Dopamine Neuron Synaptic Actions Across the Striatum and Its Relevance for Schizophrenia.

Authors:  Nao Chuhma; Susana Mingote; Abigail Kalmbach; Leora Yetnikoff; Stephen Rayport
Journal:  Biol Psychiatry       Date:  2016-07-12       Impact factor: 13.382

10.  Dopamine neurons control striatal cholinergic neurons via regionally heterogeneous dopamine and glutamate signaling.

Authors:  Nao Chuhma; Susana Mingote; Holly Moore; Stephen Rayport
Journal:  Neuron       Date:  2014-02-19       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.